STAT | A decade of reporting from the frontiers of health and medicine

Skip to Main Content

Experience STAT's journalism live at an upcoming STAT Summit

Experience STAT's journalism live at an upcoming STAT Summit

July 2, 2026

STAT Plus: Medicare takes another swing at 340B cuts to hospitals
July 2, 2026

STAT Plus: Up and down the ladder: The latest comings and goings
July 2, 2026

STAT Plus: U.S. judge blocks Colorado’s first-of-its-kind price cap on an Amgen drug
July 2, 2026

STAT Plus: Halfway into the year, biotech is booming
July 2, 2026

STAT Plus: A former AI regulator, now in industry, says biopharma is reading FDA’s guidance wrong
July 2, 2026

STAT Plus: A year after distressed buyout, what’s become of Bluebird Bio?

Test your knowledge with our now weekday mini crossword

Play the STAT Mini

The Deadliest Drug: America's alcohol epidemic hiding in plain sight

Read the series

STAT Plus: Lawmakers urge HHS to force Eli Lilly to provide 340B drug discounts to hospitals

The drug maker stopped offering discounts last month to reduce what it calls duplicate discounts paid to the hospitals

A STAT Investigation June 29, 2026

STAT Plus: The ERs that can turn patients away — and are reaping millions

In the Lab July 1, 2026

STAT Plus: Synthetic biology researchers think they’ve made a cell. Is it alive?

Business July 2, 2026

STAT Plus: Elevance sues government over $115 million tied to Medicare Advantage star ratings

The Deadliest Drug July 1, 2026

STAT Plus: Booze schmooze: The alcohol industry, frazzled by headwinds, wields its power behind the scenes

Sponsored

Advertisement

Sign up for Newsletters

STAT+

Your go-to source for the world of life sciences, medicine, and biopharma. Subscribe now.

Cancel anytime.

STAT Plus: AI company Anthropic announces it will begin developing drugs of its own

STAT Plus: U.S. judge blocks Colorado’s first-of-its-kind price cap on an Amgen drug

STAT Plus: Lawmakers urge HHS to force Eli Lilly to provide 340B drug discounts to hospitals

STAT Plus: Eli Lilly gave extraordinary obesity drug access to a 79-year-old patient. Who was it?

STAT Plus: Medicare takes another swing at 340B cuts to hospitals

All STAT+ Stories

All Events

More From STAT

More From STAT

More From STAT

STAT offers a variety of in-person and virtual events throughout the year.

All Events

AAIC Recap: What’s Next in Alzheimer’s

Virtual

Behind-the-scenes insights from the annual Alzheimer's Association International Conference in London.

2026 STAT Summit

Boston, MA

All Events

All Trackers

More From STAT

More From STAT

More From STAT

We create tools to help you understand and track complex areas of development.

All Trackers

Obesity Drug Tracker

Here are the dozens of weight loss drugs in development to catch a booming market.

CRISPR Tracker

Follow the latest developments in genome editing.

Generative AI Tracker

A guide to the health systems and companies driving adoption.

Breakthrough Device Tracker

An authoritative database of FDA’s fast-tracked medical devices.

All Reports

More From STAT

More From STAT

More From STAT

STAT Reports blend data insights with qualitative observations on pivotal life sciences topics.

All Reports

Chaotic and politicized: Inside the FDA under Trump

$49

Explore how turmoil and political pressure have destabilized the agency with mass layoffs, rapid staff departures, and a revolving door of leadership.

All Podcasts

More From STAT

More From STAT

More From STAT

From policy to practice: STAT's podcasts decode health care complexities.

All Podcasts

The Readout LOUD

Our weekly biotech podcast digs deep into industry goings-on.

First Opinion Podcast

A weekly interview show featuring the most interesting people and ideas in medicine.

Color Code

Enjoy the archives of Color Code, our podcast on racial inequities in American health care.

More From STAT

View upcoming events Play the STAT Mini Crossword Explore trackers Download our latest Report Listen to STAT podcasts

More Stories

Business July 2, 2026

STAT Plus: Medicare takes another swing at 340B cuts to hospitals

Pharmalot July 2, 2026

STAT Plus: Up and down the ladder: The latest comings and goings

Pharmalot July 2, 2026

STAT Plus: U.S. judge blocks Colorado’s first-of-its-kind price cap on an Amgen drug

Adam's Biotech Scorecard July 2, 2026

STAT Plus: Halfway into the year, biotech is booming

Health tech July 2, 2026

STAT Plus: A former AI regulator, now in industry, says biopharma is reading FDA’s guidance wrong

Biotech July 2, 2026

STAT Plus: A year after distressed buyout, what’s become of Bluebird Bio?

Health July 2, 2026

The new presidential fitness test is a positive step, not the solution, experts say

Health tech July 2, 2026

STAT Plus: A ‘historic’ FDA clearance raises the question: Is the LLM an interface or the decision-maker?

First Opinion July 2, 2026

Teens are turning to chatbots for mental health help. We need rules to keep them safe

First Opinion July 2, 2026

CDC leadership continues to try to manufacture a scientific debate on vaccines where none exists

Health July 1, 2026

Statins and blood pressure drugs changing health risks of obesity, study suggests

AI Prognosis July 1, 2026

STAT Plus: The moment Anthropic convinced me it’s serious about science

D.C. Diagnosis July 2, 2026

STAT Plus: What does DeGette’s loss mean for pharma?

The Readout July 2, 2026

STAT Plus: Roche drug sets new standard for KRAS-driven lung cancer

Pharmalot July 2, 2026

STAT Plus: Pharmalittle: We’re reading about a court win for Amgen, Novo seeking supplier discounts, and more

Morning Rounds July 2, 2026

STAT Plus: More frequent, more intense, and longer heat waves pose health risks for Americans

Pharmalot July 1, 2026

STAT Plus: Pharmalittle: We’re reading about Anthropic drug development goals, Trump drug plan snags, and more

The Readout July 1, 2026

STAT Plus: More signs that GLP-1s may help with peripheral artery disease

Adam's Biotech Scorecard July 2, 2026

STAT Plus: Halfway into the year, biotech is booming

First Opinion July 2, 2026

Teens are turning to chatbots for mental health help. We need rules to keep them safe

First Opinion July 2, 2026

CDC leadership continues to try to manufacture a scientific debate on vaccines where none exists

First Opinion July 1, 2026

Maryland Gov. Wes Moore: How to improve young men’s mental health

First Opinion July 1, 2026

What Ebola and Marburg are teaching us about the next pandemic

First Opinion June 30, 2026

Florida is the first state to require EKGs for high school athletes. It’s a mistake

Newsletters

Mon - Fri

Your daily dose of news in health and science

Our Picks

Our Picks

STAT’s selection of must-read stories and investigations

STAT Plus: Eli Lilly gave extraordinary obesity drug access to a 79-year-old patient. Who was it?

By Lizzy Lawrence

STAT Plus: Private Medicare plans erect barriers to rehab care in pursuit of profit, federal investigators find

By Casey Ross and Bob Herman

When it’s time to save a limb, novel clinic meets unhoused people where they are

By Elizabeth Cooney

‘They all think I’m insane’: What it’s like to start medical residency at 72

WHO director-general is profoundly concerned after visit to Ebola outbreak area

By Helen Branswell

Are Republicans turning against medications for treating opioid addiction?

STAT Plus: As the U.S. looks on, European countries feel growing pressure on drug prices

By Andrew Joseph

STAT Plus: Wearables, and the flood of data they generate, inch closer to entering the clinic

By Mario Aguilar

STAT Plus: The biotech scorecard for the third quarter: 15 stock-moving events to watch

Biotech July 1, 2026

STAT Plus: The biotech scorecard for the third quarter: 15 stock-moving events to watch

Biotech June 30, 2026

STAT Plus: Anthropic releases Claude Science, a product aimed at researchers, the pharma industry

Biotech June 30, 2026

STAT Plus: Abivax seeks to ease safety concerns with new data, boosting shares

STAT Plus: Pharmalittle: We’re reading about Chinese trial sites being probed, RFK Jr. and peptides, and more

Pharmalot June 30, 2026

STAT Plus: Pharmalittle: We’re reading about Chinese trial sites being probed, RFK Jr. and peptides, and more

Pharmalot June 29, 2026

STAT Plus: AstraZeneca to pay $34 million to settle kickback charges filed by Texas attorney general

Pharmalot June 29, 2026

STAT Plus: Pharmalittle: We’re reading about a broader $35 insulin cap, a former FDA cancer drug chief, and more

988’s LGBTQ+ hotline to relaunch this year. But the group that helped start it might be excluded

Health June 26, 2026

988’s LGBTQ+ hotline to relaunch this year. But the group that helped start it might be excluded

Health June 26, 2026

Jails are the frontline in fielding dangerous new type of drug withdrawal

Health June 26, 2026

What is pulmonary hypertension and why would a new GLP-1 help?

Republican Tom Kean Jr. reveals depression diagnosis after his four-month absence from Congress

Politics June 30, 2026

Republican Tom Kean Jr. reveals depression diagnosis after his four-month absence from Congress

Politics June 30, 2026

STAT Plus: The loophole in Trump’s obesity drug deal with Eli Lilly and Novo Nordisk

Politics June 25, 2026

STAT Plus: Cassidy proposes bill to rein in 340B drug discount program

Video

BIO 2026: AI, federal policy impacts, and general vibes

What’s next for GLP-1 weight loss drugs?

How a diabetes conference sparked a controversy

What happens at a longevity festival?

STAT Plus: All of Us tests a new approach to collect real-world data for research

Health tech June 30, 2026

STAT Plus: All of Us tests a new approach to collect real-world data for research

Health tech June 29, 2026

STAT Plus: Sword Health contracted to provide AI-supported physical therapy for an entire country

Health tech June 25, 2026

STAT Plus: FDA gives generative AI in radiology two breakthrough designation nods

STAT Plus: Next-gen CRISPR tools improve editing accuracy in embryos, but also stoke ethical concerns

In the Lab June 25, 2026

STAT Plus: Next-gen CRISPR tools improve editing accuracy in embryos, but also stoke ethical concerns

In the Lab June 17, 2026

NIH diversity programs doubled undergraduates’ odds of getting a Ph.D., 20-year study finds

In the Lab June 16, 2026

STAT Plus: Human Cell Atlas leader’s tie to 10x Genomics raises conflict-of-interest questions

Judge temporarily blocks subpoenas in criminal probe of transgender care at New York hospitals

Hospitals June 24, 2026

Judge temporarily blocks subpoenas in criminal probe of transgender care at New York hospitals

Hospitals April 14, 2026

STAT Plus: Dana-Farber CEO talks untangling from Mass General Brigham and building new cancer hospital

Hospitals March 13, 2026

STAT Plus: Leapfrog Group’s legal defeat underscores challenges of rating hospital quality

STAT Plus: 26 states sue to block Medicaid work requirements

Insurance June 29, 2026

STAT Plus: 26 states sue to block Medicaid work requirements

Insurance May 21, 2026

STAT Plus: Elevance executive ordered to testify in Medicare Advantage fraud case

Insurance May 18, 2026

STAT Plus: Trump’s CMS to allow skimpier plans on ACA exchanges

Podcasts

The mysterious case of Eli Lilly’s obesity drug

How STAT decided to keep ‘health care’ as two words

STAT Plus: An obesity drug deep-dive, and peptides move mainstream

‘They all think I’m insane’: What it’s like to start medical residency at 72